Global Calculus Bovis Market Strategic Research Report

Scope of the Report

The global Calculus Bovis market size is predicted to grow from US$ 215 million in 2025 to US$ 582 million in 2032; it is expected to grow at a CAGR of 15.4% from 2026 to 2032.

Bezoar is a bovine gallstone used in traditional Chinese medicine. In countries such as China and Japan, it has long been used to treat a variety of diseases, including high fever, convulsions and stroke. In Asian countries, cattle stones are sometimes harvested when cattle are slaughtered. Bezoar is a dried gallstone of cattle, a mammal of the phylum Chordata. Those produced in the gallbladder are called "bile yellow" or "egg yolk", those produced in the bile duct are called "tube yellow", and those produced in the hepatic duct are called "liver yellow". The complete bezoar is mostly oval in shape, light in texture, with a golden to yellow-brown surface, delicate and shiny. Traditional Chinese medicine believes that bezoar has a fresh fragrance, a slightly bitter taste and then sweet, and a cool nature. It can be used to relieve fever, detoxify, and calm the nerves. It can be taken internally to treat high fever, coma, mania, infantile convulsions, convulsions, etc. It can be used externally to treat sore throat, mouth sores, carbuncle, and toxicity.

Because natural bezoar is extremely rare and cannot be produced industrially. Therefore, this report mainly counts two types of products: in vitro cultivated bezoar and artificial bezoar.

The global key manufacturers of calculus bovis include Jianmin Group, Dibo Pharmaceuticals, Mingxing Pharmaceuticals, Renqi Pharmaceuticals, Hongmao Pharmaceuticals, and Tongrentang. The top five manufacturers together account for 80% of the market share, with Jianmin Group being the largest producer with 20% of the market share. The global origin is mainly concentrated in China. At the consumer level, China holds close to 90% of the market share. In terms of product category, it is divided into in vitro calculus bovis and artificial bezoar, with the former having a higher market share of 75%. In terms of its application,preparations medicine is its top application area with 95% market share, followed by Chinese hebal medicine.

The driving factors of the bezoar market mainly include

1. Resource scarcity: rigid constraints on the supply of natural bezoar

Production bottleneck

Cause: Bezoar is a pathological product. Only 0.1%-0.2% of cattle gallstones can form natural bezoar, and the breeding cycle is long (requires 3-5 years).

2. Policy control: industry access and standard upgrade

Production license control

China only allows 6 companies (such as Jianmin Group and Tongrentang) to produce natural bezoar, and implements a quota system with an annual quota of less than 800 kilograms.

The 2025 edition of the "Chinese Pharmacopoeia" raises the detection standard for bezoar content, and the impurity limit is tightened from 2% to 0.5%, forcing companies to optimize procurement and processing technology.

3. Consumption upgrade: Demand for high-end Chinese medicine explodes

Chinese patent medicine field

Angong Niuhuang Wan: The core raw material bezoar accounts for 10%, and the annual demand exceeds 200 tons, driving the use of bezoar to increase by 15%.

Pianzaihuang: The unit price of natural bezoar formula products exceeds 1,000 yuan/tablet, and sales increase by 20% year-on-year.

Health products and cosmeceuticals extension

Bezoar toothpaste: adding trace amounts of bezoar ingredients, the unit price is 5 times that of ordinary toothpaste, and the market share increases by 25% annually.

Anti-aging products: bezoar extract is used for high-end skin care, and the target customer group CAGR reaches 30%.

IV. Technology substitution: breakthrough in in vitro cultivation of bezoar

Industrialization process is accelerated

Wuhan Jianmin Dapeng Pharmaceutical has achieved large-scale production of in vitro cultivated bezoar, with a cost of only 1/10 of natural bezoar and an annual production capacity of 5 tons.

Efficacy verification: The State Food and Drug Administration has approved it to replace natural bezoar for 42 kinds of Chinese patent medicines, covering 80% of bezoar preparations.

Market penetration rate increases

In vitro cultivated bezoar has a market share of more than 60% in the low- and medium-end markets, squeezing out the demand for natural bezoar, but it is still irreplaceable in the high-end field.

V. Capital drive: industrial chain integration and financialization

Upstream resource monopoly

Pianzihuang and Tongrentang lock in cattle sources by holding overseas ranches.

Futures and financial derivatives

Bezoar futures are listed on the Bozhou Chinese Medicine Exchange, with an annual trading volume of over 5 billion yuan. The price discovery function reduces corporate procurement risks.

6. Cultural beliefs: Traditional medical cognition is solidified

The status of the pharmacopoeia is unshakable

The "Shennong Bencao Jing" lists bezoar as a top-grade product, and its status as the first of the "three treasures of cold water" in traditional Chinese medicine theory deepens consumer cognition.

Gift attributes are strengthened

Natural bezoar products have become high-end gifts, and the annual sales of bezoar handicrafts with a unit price of more than 100,000 yuan exceeds 1 billion yuan.

7. Challenges and coping strategies

Sustainable supply problems

Countermeasures: Promote in vitro cultivation technology, develop synthetic biology pathways for bezoar, and reduce dependence on natural resources.

Price volatility risk

Countermeasures: Establish a national strategic reserve system, improve hedging tools in the futures market, and smooth the cost curve of enterprises.

The bezoar market is a typical scenario of resource scarcity, policy control, consumption upgrades and technological substitution resonance. In the future, the industry will present the triple trends of "high-end natural bezoar, large-scale in vitro cultivation, and financialization of the industrial chain." Enterprises need to seek a balance between supply constraints and demand explosion through technological breakthroughs, resource monopoly and cultural marketing, and dominate the market structure in the next decade.

This report presents a comprehensive overview of the global Calculus Bovis market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Artificial Bezoar
• In Vitro Cultured Bezoar

Segment by Application

• Preparations Medicine
• Chinese Herbal Medicine

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Calculus Bovis market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Preparations Medicine, Chinese Herbal Medicine evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact